HomeNPCE • NASDAQ
add
Neuropace Inc
Previous close
$16.50
Day range
$16.13 - $16.64
Year range
$7.56 - $18.97
Market cap
541.21M USD
Avg Volume
238.17K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 27.35M | 29.89% |
Operating expense | 23.77M | 20.88% |
Net income | -3.50M | 35.88% |
Net profit margin | -12.78 | 50.64% |
Earnings per share | -0.11 | 42.11% |
EBITDA | -2.55M | 39.19% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 60.01M | 5.60% |
Total assets | 107.26M | 11.37% |
Total liabilities | 88.74M | 2.61% |
Total equity | 18.52M | — |
Shares outstanding | 33.31M | — |
Price to book | 29.46 | — |
Return on assets | -6.09% | — |
Return on capital | -7.20% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -3.50M | 35.88% |
Cash from operations | -1.94M | -12.76% |
Cash from investing | -30.00K | -102.14% |
Cash from financing | -235.00K | -108.11% |
Net change in cash | -2.21M | -185.82% |
Free cash flow | -814.12K | -2,221.50% |
About
Founded
1997
Website
Employees
209